[New horizons in influenza prevention].
Sierra Madero
J G
JG
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D000940:Antigenic Variation; D000956:Antigens, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000627:therapeutic use; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006801:Humans; D009980:Influenza A virus / Q000276:immunology / Q000302:isolation & purification; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D008168:Lung / Q000821:virology; D051379:Mice; D010446:Peptide Fragments / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000276:immunology; D014613:Vaccines, Attenuated; D014763:Viral Matrix Proteins / Q000276:immunology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D000998:Antiviral Agents; D006512:Hepatitis B Core Antigens; D007252:Influenza Vaccines; C031540:M-protein, influenza virus; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins; D014613:Vaccines, Attenuated; D014763:Viral Matrix Proteins